Topical 5-Fluorouracil 0.5% as primary treatment for Ocular Surface Squamous Neoplasia.
Gabriela Carneiro TeixeiraMateus Inacio Lemes de ResendeMelina Correia MoralesArthur Gustavo FernandesPublished in: European journal of ophthalmology (2024)
Topical 5-FU 0.5% is an effective therapeutic option in the treatment of OSSN, with an 80% therapeutic success rate, showing good tolerability. The size of the lesion was identified as a factor influencing treatment success, therefore it should be taken into consideration when defining treatment approaches.